Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Agilon Health reports 75% revenue surge in Q3 2023, maintains net loss

EditorPollock Mondal
Published 03/11/2023, 10:36
© Reuters.
AGL
-

Agilon Health Inc. revealed a significant revenue increase in its Q3 2023 earnings report, with a surge of 75% to $1.22 billion from $695 million in the same quarter of the previous year. This growth was driven by the physician network, which boosted the Medicare Advantage membership by 58% to 420,300 and total platform membership (including ACO REACH populations) to 508,000, leading to improved patient outcomes.

Despite this strong performance in revenue and membership growth, Agilon reported a consistent net loss of $31 million with Q3 2022. The company also reported a gross profit of $30 million. As part of its strategy to focus on partner markets and position partner groups for success into 2024, Agilon sold MDX Hawaii.

Excluding MDX Hawaii, Agilon's guidance for fiscal year 2023 projects revenues between $4.31 billion and $4.32 billion, a medical margin from $455 million to $470 million, and adjusted EBITDA between $6 million and $18 million according to the company's 8-K earnings release.

On the other hand, SB Financial Group Inc experienced a downturn in Q3 2023, with a 19.6% decrease in net income year-on-year. This happened despite a 25.8% rise in interest income and a 3% increase in noninterest income from Q3 2022 levels. The operating revenue dropped by 5.3% to $13.7 million.

The firm saw interest income rise to $14.8 million, but net interest income fell by 8.6% to $9.5 million. Noninterest income and expense saw minor increases to $4.2 million and $10.5 million respectively, while total loans held for investment grew by 6.9%. Deposit balances remained steady at $1.09 billion, with nonperforming assets reported at $4 million.

CEO Mark A. Klein indicated that funding costs were a challenge for the company, which reported shareholders equity of $112.3 million and an allowance percentage of 1.60%.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.